CEL-SCI (CVM) Stock Chart & Stock Price History → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free CVM Stock Alerts $1.44 -0.01 (-0.69%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media CEL-SCI Stock Price Performance5 Day Performance-7.69%1 Month Performance-23.40%3 Month Performance-50.00%6 Month Performance+6.67%Year-To-Date Performance-47.06%1 Year Performance-36.56% Receive CVM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. CVM Stock Chart for Friday, April, 26, 2024 CVM Chart by TradingView CEL-SCI Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.46$1.44-1.37%$1.48$1.39136,575 shs$77.73 million04/25/2024$1.45$1.46+0.69%$1.47$1.4181,960 shs$78.81 million04/24/2024$1.46$1.45-0.34%$1.47$1.4476,087 shs$78.27 million04/23/2024$1.51$1.46-3.64%$1.53$1.44185,868 shs$78.54 million04/22/2024$1.56$1.51-3.21%$1.57$1.50123,696 shs$81.51 million04/19/2024$1.52$1.56+2.63%$1.57$1.50227,075 shs$84.21 million Get the Latest News and Ratings for CVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$1.50$1.52+1.33%$1.60$1.51155,910 shs$82.05 million04/17/2024$1.52$1.50-1.32%$1.60$1.50133,503 shs$80.97 million04/16/2024$1.58$1.52-3.80%$1.57$1.50171,172 shs$82.05 million04/15/2024$1.63$1.58-3.07%$1.68$1.53175,064 shs$85.29 million04/12/2024$1.66$1.63-1.81%$1.67$1.59117,408 shs$87.99 million04/11/2024$1.66$1.66+0.30%$1.71$1.56262,723 shs$89.61 million04/10/2024$1.71$1.66-3.22%$1.69$1.63148,631 shs$89.34 million04/09/2024$1.78$1.71-3.93%$1.81$1.65154,015 shs$92.31 million04/08/2024$1.77$1.78+0.56%$1.85$1.65284,226 shs$96.08 million04/05/2024$1.72$1.77+2.91%$1.82$1.69171,590 shs$95.55 million04/04/2024$1.83$1.72-6.01%$1.88$1.72179,935 shs$92.85 million04/03/2024$1.78$1.83+3.10%$1.88$1.74140,978 shs$98.78 million04/02/2024$1.83$1.78-3.01%$1.78$1.69243,390 shs$95.81 million04/01/2024$1.91$1.83-4.19%$1.91$1.71188,017 shs$98.78 million03/29/2024$1.91$1.91$1.91$1.81101,904 shs$103.10 million03/28/2024$1.89$1.91+1.06%$1.91$1.81101,867 shs$103.10 million03/27/2024$1.88$1.89+0.53%$1.94$1.84229,461 shs$102.02 million03/26/2024$1.65$1.88+13.94%$1.91$1.67475,687 shs$101.48 million03/25/2024$1.83$1.65-9.84%$1.83$1.63674,187 shs$89.07 million03/22/2024$1.89$1.81-3.98%$1.96$1.79397,414 shs$97.70 million03/21/2024$1.97$1.89-4.07%$2.04$1.83539,350 shs$101.75 million03/20/2024$2.03$1.97-3.20%$2.04$1.95288,785 shs$106.07 million03/19/2024$2.04$2.03-0.49%$2.08$2.00216,913 shs$109.58 million03/18/2024$2.01$2.04+1.49%$2.09$2.00206,696 shs$110.12 million03/15/2024$2.12$2.02-4.49%$2.16$2.02439,373 shs$109.04 million03/14/2024$2.08$2.12+1.68%$2.19$2.01280,476 shs$114.17 million03/13/2024$2.11$2.08-1.42%$2.15$2.06194,463 shs$112.28 million03/12/2024$2.21$2.11-4.52%$2.25$2.11271,525 shs$113.90 million03/11/2024$2.29$2.21-3.49%$2.34$2.20171,507 shs$119.30 million03/08/2024$2.28$2.29+0.44%$2.39$2.27186,944 shs$123.61 million03/07/2024$2.41$2.28-5.39%$2.50$2.25459,165 shs$123.07 million03/06/2024$2.23$2.41+8.07%$2.45$2.26406,318 shs$130.09 million03/05/2024$2.31$2.23-3.46%$2.33$2.19162,424 shs$120.38 million03/04/2024$2.24$2.31+3.12%$2.39$2.24249,039 shs$124.69 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$2.08$2.25+8.17%$2.27$2.08226,611 shs$121.46 million02/29/2024$2.02$2.08+2.97%$2.15$2.04333,241 shs$112.28 million02/28/2024$2.03$2.02-0.25%$2.08$2.00507,142 shs$109.04 million02/27/2024$2.00$2.03+1.25%$2.06$1.96450,071 shs$109.31 million02/26/2024$2.13$2.00-6.10%$2.15$2.00878,258 shs$107.96 million02/23/2024$2.15$2.12-1.40%$2.23$2.10524,684 shs$114.44 million02/22/2024$2.14$2.15+0.47%$2.22$2.13294,474 shs$116.06 million02/21/2024$2.24$2.14-4.46%$2.26$2.14721,429 shs$115.52 million02/20/2024$2.34$2.24-4.27%$2.40$2.20661,519 shs$120.92 million02/19/2024$2.34$2.34$2.39$2.31245,000 shs$126.31 million02/16/2024$2.35$2.34-0.43%$2.38$2.31244,517 shs$126.31 million02/15/2024$2.38$2.35-1.26%$2.42$2.31341,218 shs$117.74 million02/14/2024$2.29$2.38+3.93%$2.38$2.30274,749 shs$119.25 million02/13/2024$2.38$2.29-3.58%$2.39$2.28444,422 shs$114.45 million02/12/2024$2.46$2.38-3.46%$2.47$2.34404,833 shs$118.70 million02/09/2024$2.83$2.46-13.07%$2.58$2.331.34 million shs$122.95 million02/08/2024$2.89$2.83-1.91%$2.90$2.77143,278 shs$141.44 million02/07/2024$3.08$2.89-6.33%$3.05$2.85204,265 shs$144.19 million02/06/2024$2.92$3.08+5.48%$3.08$2.90322,819 shs$153.94 million02/05/2024$2.82$2.92+3.55%$2.98$2.80269,854 shs$145.94 million02/02/2024$2.77$2.82+1.99%$2.85$2.65207,292 shs$140.94 million02/01/2024$2.87$2.77-3.66%$2.92$2.73172,583 shs$138.20 million01/31/2024$2.80$2.87+2.50%$3.08$2.82639,274 shs$143.44 million01/30/2024$2.86$2.80-2.10%$2.89$2.75124,074 shs$139.94 million01/29/2024$2.88$2.86-0.69%$2.92$2.79183,904 shs$142.94 million01/26/2024$2.68$2.88+7.46%$2.94$2.68335,841 shs$143.94 million01/25/2024$2.62$2.68+2.29%$2.76$2.58158,016 shs$133.95 million Related Companies: Curis Stock Chart Protalix BioTherapeutics Stock Chart AlloVir Stock Chart Athira Pharma Stock Chart Atara Biotherapeutics Stock Chart Sangamo Therapeutics Stock Chart Gritstone bio Stock Chart Cognition Therapeutics Stock Chart Genenta Science Stock Chart Passage Bio Stock Chart Receive CVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CVM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.